FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
February 13, 2003
Commission File Number 001-16625
BUNGE LIMITED
(Translation of registrant's name into English)
50 Main Street
White Plains, New York 10606
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:
Form 20-F X Form 40-F
--- ---
Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7):
Indicate by check mark whether by furnishing the information contained
in this Form the registrant is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes No X
--- ---
If "Yes" is marked, indicate below the file number assigned to the
registrant with Rule 12g3-2(b): 82-
EXHIBITS
--------
Exhibit 1 Press release dated February 13, 2003 announcing expiration of
Hart-Scott-Rodino waiting period for Bunge Limited-Dupont
joint venture
SIGNATURES
----------
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
Date: February 13, 2003 Bunge Limited
By: /s/ William M. Wells
---------------------------
William M. Wells
Chief Financial Officer
Exhibit 1
[BUNGE Logo] Contact: Stewart Lindsay
Edelman Public Relations
1-212-704-4435
stewart.lindsay@edelman.com
HART-SCOTT-RODINO WAITING PERIOD EXPIRES ON BUNGE
LIMITED - DUPONT JOINT VENTURE
WHITE PLAINS, NY - February 13, 2002 - Bunge Limited (NYSE: BG) today announced
that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act
of 1976 has expired concerning the company's proposed joint venture with DuPont.
Formation of the joint venture requires additional regulatory approvals.
Bunge and DuPont announced their intention to form a joint venture of their soy
ingredient businesses on January 6, 2003. The joint venture, Solae L.L.C., will
participate in the rapidlygrowing market for high-quality, nutritious food
proteins. It is expected to begin later this year, with total initial annual
revenues of approximately $800 million.
About Bunge Limited
Bunge Limited (www.bunge.com) is an integrated, international agribusiness and
food company operating in the farm-to-consumer food chain with worldwide
distribution capabilities and primary operations in North America, South America
and Europe. Headquartered in White Plains, New York, Bunge has over 24,000
employees and locations in 28 countries. Bunge is the largest processor of
soybeans in the Americas, the world's leading oilseed processing company, the
largest producer and supplier of fertilizers to farmers in South America and the
world's leading seller of bottled vegetable oils to consumers.
Cautionary Statement Concerning Forward-Looking Statements
This press release contains both historical and forward-looking statements. All
statements, other than statements of historical fact are, or may be deemed to
be, forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities Exchange
Act of 1934, as amended. These forward-looking statements are not based on
historical facts, but rather reflect our current expectations and projections
about our future results, performance, prospects and opportunities. We have
tried to identify these forward-looking statements by using words including
"may," "will," "expect," "anticipate," "believe," "intend," "estimate" and
"continue" and similar expressions. These forward-looking statements involve
known and unknown risks, uncertainties and other factors that could cause our
actual results, performance, prospects or opportunities to differ materially
from those expressed in, or implied by, these forward-looking statements. The
following important factors, among others, could affect future results, causing
them to differ materially from those expressed in our forward-looking
statements: our ability to complete, integrate and benefit from acquisitions,
divestitures, joint ventures and alliances, , estimated demand for commodities
and other products that we sell and use in our business; industry conditions,
including the cyclicality of the agribusiness industry; economic and political
conditions in Brazil and Argentina; and other economic,
business, competitive and/or regulatory factors affecting our business
generally. The forward-looking statements included in this release are made only
as of the date of this release, and except as otherwise required by federal
securities law, we do not have any obligation to publicly update or revise any
forward-looking statements to reflect subsequent events or circumstances.